AQP4 and neuromyelitis optica: 2.3. Intrathecal Co-Administration of IVIg Is Effective in Reducing the Pathogenic Effects of NMO-IgG and of Recombinant Human Autoantibodies to Aquaporin-4 (rAB-AQP4)